Skip to main navigation Skip to search Skip to main content

Development of a lateral flow aptamer assay strip for facile identification of theranostic exosomes isolated from human lung carcinoma cells

  • Qiang Yu
  • , Qu Zhao
  • , Sai Wang*
  • , Shuai Zhao
  • , Shan Zhang
  • , Yingai Yin
  • , Yiyang Dong*
  • *Corresponding author for this work

Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

Abstract

Exosomes are Extracellular Vesicles (EV) that own unique structural features and functions and have gradually become the hot research spot in recent years. The tumor-derived exosomes contain various types of useful biological information, and medical identification of exosomes relied on the specific characterization of membrane surface proteins. In this study, in order to rapidly identify non-small cell lung cancer (NSCLC)-derived exosomes, based on an aptamer against CD63 protein on exosome membrane, a low cost lateral flow aptamer assay (LFAA) test strip using nanogold particles as visualization probes was successfully developed for facile identification of A549 exosomes isolated from human lung carcinoma cells diluted from 6.4 x 109 particles/mL herein.
Original languageEnglish
Article number113591
JournalAnalytical Biochemistry
Volume594
Online published20 Jan 2020
DOIs
Publication statusPublished - 1 Apr 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Keywords

  • Exosomes
  • Aptamer
  • Lateral flow aptamer assay (LFAA)
  • Non-small cell lung cancer (NSCLC)

Fingerprint

Dive into the research topics of 'Development of a lateral flow aptamer assay strip for facile identification of theranostic exosomes isolated from human lung carcinoma cells'. Together they form a unique fingerprint.

Cite this